169326 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#2DIGITAL PROTEIN QUANTIFICATION
#3SYSTEMS, METHODS AND COMPOSITIONS FOR ANALYSIS OF PROTEOFORMS
#4SYSTEMS FOR ASSAYING PROTEINS
#5METHODS OF ASSAYING PROTEINS
#6PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING
#7IDENTIFICATION OF TDP-43 CRYPTIC EXON-ENCODED NEOEPITOPES AS FUNCTIONAL FLUID BIOMARKERS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIA
#8INHIBITORS OF COMPLEMENT FACTOR H
#9BIGLYCAN PEPTIDE AND ANTIBODIES
#10METHODS AND SYSTEMS FOR DEVELOPING PERSONALIZED VACCINE BY IDENTIFICATION AND PRIORITIZATION OF MUTATION-DERIVED NEOANTIGENS
#11METHODS FOR PREDICTING THE USEFULNESS OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY
#12Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#13METHOD FOR DETECTING MULTIMERIC, PREFERABLY DIMERIC PEPTIDES USING SINGLE-DOMAIN ANTIBODIES
#14EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS
#15TWO-DIMENSIONAL MATRIX DROPLET ARRAY
#16Protein array-based in vitro transglutaminase assay platform for epitope mapping and immunogen design
#17METHODS AND SYSTEMS FOR ASSESSING IMMUNE CELL RECEPTORS AND ANTIGENS
#18ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF
#19COMPOSITIONS AND METHODS FOR IMPROVING AFFINITY REAGENT AVIDITY
#20IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION
#21METHODS AND DEVICES FOR DETECTING CEREBROSPINAL FLUID LEAKAGE
#22Methods and compositions for assessing antibody specificities
#23REDUCING JUNCTION EPITOPE PRESENTATION FOR NEOANTIGENS
#24Inhibitors of complement factor H
#25METHOD FOR IDENTIFYING T-CELL EPITOPE SEQUENCE, AND APPLICATION OF SAME
#26METHOD FOR PREDICTING THE OFF-TARGET BINDING OF A PEPTIDE WHICH BINDS TO A TARGET PEPTIDE PRESENTED BY A MAJOR HISTOCOMPATIBILITY COMPLEX
#27METHOD FOR THE ABSOLUTE QUANTIFICATION OF NATURALLY PROCESSED HLA-RESTRICTED CANCER PEPTIDES
#28ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCII PEPTIDE BINDING
#29VARIANT LIBRARY-COUPLED IMMUNOGENICITY MAPPING OF MONOCLONAL ANTIBODY THERAPEUTICS
#30COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#31MULTIPLEXED IMMUNOHISTOCHEMISTRY USING RECOMBINANT ANTIBODIES WITH EPITOPE TAGS
#32PURIFICATION OF HLA-SPECIFIC ANTIBODIES
#33METHOD FOR EPITOPE BINNING OF NOVEL MONOCLONAL ANTIBODIES
#34Peptide of Norovirus Origin, Polynucleotide, Antibody, Composition, Method for Identifying Neutralizing Epitope for Norovirus
#35Epitope of Regulatory T Cell Surface Antigen, and Antibody Specifically Binding Thereto
#36COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#37SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES
#38MICROBIOTA SEQUENCE VARIANTS OF TUMOR-RELATED ANTIGENIC EPITOPES
#39Methods and compositions for assessing antibody specificities
#40METHODS AND SYSTEMS FOR SELECTIVE QUANTITATION AND DETECTION OF ALLERGENS INCLUDING GLY M 7
#41METHODS AND SYSTEMS FOR PERSONALIZED NEOANTIGEN PREDICTION
#42DIGITAL PROTEIN QUANTIFICATION
#43HLA-BASED METHODS AND COMPOSITIONS AND USES THEREOF
#44METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#45Systems, Compositions, And Methods For Discovery Of MSI And Neoepitopes That Predict Sensitivity To Checkpoint Inhibitors
#46CD1 PEPTIDE-EPITOPE FOR USE IN THE TREATMENT OF A DISEASE CAUSED BY AN INTRACELLULAR PATHOGEN
#47COMBINATORIAL SINGLE MOLECULE ANALYSIS OF CHROMATIN
#48Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing
#49METHOD FOR DETERMINING THE POTENCY OF ANTIGENS
#50Method and device for screening antigen epitope polypeptide
#51ADA-RESPONSE SPECIFICATION ASSAY
#52TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
#53Polyclonal mixtures of antibodies, and methods of making and using them
#54MISFOLDED SOD1 ASSAY
#55COMPUTER ASSISTED ANTIBODY RE-EPITOPING
#56COMPOSITIONS AND METHODS FOR IDENTIFYING MHC-II BINDING PEPTIDES
#57HER3 PULSED DC1 THERAPY
#58Method for identifying T-cell epitopes
#59Methods for Treating Breast Cancer and for Identifying Breast Cancer Antigens
#60SELECTION OF T CELL RECEPTORS
#61Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
#62ASSAY DETECTION METHODS FOR VCAM-1 AND CALPROTECTIN
#63TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#64Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH
#65HLA SINGLE ALLELE LINES
#66PEPTIDE MICROARRAYS AND NOVEL BIOMARKERS FOR CELIAC DISEASE
#67Identification of a T cell epitope of that induces T cell responses in patients with rheumatoid arthritis
#68Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex
#69FLOW CYTOMETRY FOR MONITORING HISTONE H3 METHYLATION STATUS
#70Methods of immunogenic modulation
#71SPR-BASED BRIDGING ASSAY FORMAT FOR DETERMINING THE BIOLOGICAL ACTIVITY OF MULTIVALENT, MULTISPECIFIC MOLECULES
#72Bead-based assays for protein analysis
#73METHODS FOR IDENTIFYING RNA EDITING-DERIVED EPITOPES THAT ELICIT IMMUNE RESPONSES IN CANCER
#74Methods and compositions for assessing antibody specificities
#75Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#76MAMMALIAN MHC PEPTIDE DISPLAY AS AN EPITOPE SELECTION TOOL FOR VACCINE DESIGN
#77PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT)
#78SYSTEMS AND METHODS OF EPITOPE BINNING AND ANTIBODY PROFILING
#79CLAUDIN-6 PEPTIDES
#80METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES
#81Reducing junction epitope presentation for neoantigens
#82METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#83IMMUNE RECOGNITION MOTIFS
#84Epitope-targeted peptide immunostimulants
#85Anti-human migration stimulating factor (MSF) and uses thereof
#86Polyclonal mixtures of antibodies, and methods of making and using them
#87ANTIBODY VALIDATION USING IP-MASS SPECTROMETRY
#88Microbiota Sequence Variants Of Tumor-Related Antigenic Epitopes
#89T-CELL EPITOPE IDENTIFICATION
#90METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES
#91METHODS FOR ASSESSING GRAFT FAILURE RISK
#92NEOANTIGEN ANALYSIS
#93System and method of data-dependent acquisition by mass spectrometry
#94IDENTIFICATION OF IMMUNOGENIC MUTANT PEPTIDES USING GENOMIC, TRANSCRIPTOMIC AND PROTEOMIC INFORMATION
#95IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES
#96HLA-based methods and compositions and uses thereof
#97Method for the absolute quantification of naturally processed hla-restricted cancer peptides
#98HLA-based methods and compositions and uses thereof
#99Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library
#100COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#101Multi-protease method
#102Methods and kits for determining binding sites
#103Microbiota sequence variants of tumor-related antigenic epitopes
#104Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
#105Compositions and Methods of Identifying Tumor Specific Neoantigens
#106Methods and systems for selective quantitation and detection of allergens including Gly m 7
#107Detecting Gluten Peptides in Human Fluids
#108VALIDATION OF NEOEPITOPE-BASED TREATMENT
#109IDENTIFICATION AND GENERATION OF PERSONALIZED VACCINE COMPONENTS BY FUNCTIONAL SCREENING VARIABLE EPITOPE AND MIMOTOPE LIBRARIES
#110Anti-complement factor H antibodies
#111Combinatorial single molecule analysis of chromatin
#112Neoantigen identification using hotspots
#113COMPOSITIONS AND METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES
#114Immunogenic proteins and fragments thereof from allergenic mites
#115Identification of antigen epitopes and immune sequences recognizing the antigens
#116Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
#117PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT)
#118Aldehyde scavenging agent for retrieving elements from fixed tissue
#119Identification of a T cell epitope of that induces T cell responses in patients with Rheumatoid arthritis
#120Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
#121Methods for epitope mapping
#122Monitoring and diagnosis for immunotherapy, and design for therapeutic agent
#123Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#124COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#125Methods for treating breast cancer and for identifying breast cancer antigens
#126CRISPR-associated (Cas) proteins with reduced immunogenicity
#127COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#128Biochemical Markers for Pulmonary and Other Diseases
#129Method of obtaining a binder to prepro-vasopressin or fragments thereof
#130Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile and spreading
#131Methods and systems for predicting alloreactivity in transplantation
#132Functional characterization of immune repertoires
#133Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#134Computer assisted antibody re-epitoping
#135DIAGNOSTIC AND THERAPEUTIC EPITOPE, AND TRANSGENIC PLANT
#136COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#137T-cell epitope identification
#138Methods and antibodies for designing and detecting mutation-specific or hidden epitope/antigena
#139MHC-I restricted epitopes containing non-natural amino acid residues
#140Potent anti-influenza A neuraminidase subtype N1 antibody
#141Peptide microarrays and novel biomarkers for celiac disease
#142METHODS OF IDENTIFYING ANTIGENS FOR VACCINES
#143METHOD FOR DETECTING A SPATIAL PROXIMITY OF A FIRST AND A SECOND EPITOPE
#144IDENTIFICATION OF IMMUNOLOGICALLY PROTECTIVE NEO-EPITOPES FOR THE TREATMENT OF CANCERS
#145ANTIBODY GUIDED VACCINES AND METHODS OF USE FOR GENERATION OF RAPID MATURE IMMUNE RESPONSES
#146Digital protein quantification
#147Method of retrieving elements from fixed tissue
#148Identifying peptides having T-cell-exposed motifs with known frequency of occurrence in a reference database
#149DETECTING GLUTEN PEPTIDES IN HUMAN FLUIDS
#150METHOD FOR RISK ASSESSMENT OF ALLERGIC REACTION
#151Systems and methods of epitope binning and antibody profiling
#152METHOD AND DEVICE FOR STABILIZING OF PROTEINS
#153Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways
#154Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors
#155Antibodies to sericin and methods and kits using same
#156Compositions and methods for screening T cells with antigens for specific populations
#157Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#158Biological sensing method for separating biomolecule
#159Biochemical markers for pulmonary and other diseases
#160Polyclonal mixtures of antibodies, and methods of making and using them
#161Anti-Complement factor H antibodies
#162Biochemical markers for CVD risk assessment
#163BIOLOGICAL SENSING DEVICE AND METHOD FOR SEPARATING BIOMOLECULE
#164Cyclic peptide binder against oncogenic K-Ras
#165Antibodies and methods for detecting and isolating the common conjugation site-specific epitopes/antigens
#166Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
#167Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information
#168Generating peptoid vaccines
#169PIIINP neo-epitope assay
#170MAMMALIAN PROTEIN CO-RECOGNITION BY BROADLY NEUTRALIZING ANTIBODIES AS MODIFIED IMMUNOGENS FOR RE-ELICITATION
#171MHC-I restricted epitopes containing non-natural amino acid residues
#172Antibodies that bind to human programmed death ligand 1 (PD-L1)
#173BIOMARKER METHODS AND COMPOSITIONS
#174Determining pathological cartilage turnover
#175Cross-reactive determinants and methods for their identification
#176Method for predicting the off-target biding of a peptide which binds to a target peptide presented by a major histocompatibility complex
#177Method for prediction of an immune response against mismatched human leukocyte antigens
#178Methods of detecting conjugation site-specific and hidden epitope/antigen
#179Neo antibodies for diagnostic imaging of tissue injury
#180Eukaryotic expression system and use thereof
#181Biochemical markers for CVD risk assessment
#182Crystal Structure of a NEF/SdAb19 Complex and Uses Thereof
#183Comparative Ligand Mapping from MHC Positive Cells
#184Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
#185Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#186Epitope testing using soluble HLA
#187Assay method for peptide specific T-cells
#188Neoantibodies for diagnosing tissue injury
#189MHC-I restricted epitopes containing non-natural amino acid residues
#190DIAGNOSIS AND THERAPEUTIC EPITOPE, AND TRANSGENIC PLANT
#191VACCINES
#192Designer peptide-based PCV2 vaccine
#193Human monoclonal antibodies to the thyrotropin receptor which act as antagonists
#194Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
#195Methods for Screening Viral Like Particles and Identifying Neutralizing Epitopes and Related Vaccines, Constructs, and Libraries
#196COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#197Peptide microarray and method of use
#198AUTOMATED MULTIPLEX IMMUNOASSAY
#199Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
#200IMMUNODOMINANT MHC DR52B RESTRICTED NY-ESO-1 EPITOPES, MHC CLASS II MONOMERS AND MULTIMERS, AND USES THEREOF
#201Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
#202EPITOPE TESTING USING SOLUBLE HLA
#203Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Additional Quantifiable Extenders
#204COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#205COMPARATIVE LIGAND MAPPING FROM MHC POSITIVE CELLS
#206MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN
#207METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#208Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy
#209Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
#210Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
#211Compositions and methods of identifying tumor specific neoantigens
#212System and method of data-dependent acquisition by mass spectrometry
#213COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#214Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#215Cytokines and Cytokine Receptors with Reduced Immunogenicity
#216Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
#217ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS
#218Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#219Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments
#220Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways
#221PROTEIN SPLICE VARIANT / ISOFORM DISCRIMINATION AND QUANTITATIVE MEASUREMENTS THEREOF
#222Method of determination of receptor binding saturation effected by monoclonal antibodies
#223Assay for diagnosis of cardiac myocyte damage
#224EPITOPE TESTING USING SOLUBLE HLA
#225Diagnostic and therapeutic epitope, and transgenic plant
#226Antibody categorization based on binding characteristics
#227PAX2 AND PAX8 AS TUMOUR TARGETS FOR IMMUNOLOGIC AND MOLECULAR TREATMENT STRATEGIES
#228Cross-reactive determinants and methods for their identification
#229PROTEIN BIOCHIP FOR THE DIFFERENTIAL SCREENING OF PROTEIN-PROTEIN INTERACTIONS
#230METHOD FOR DETECTING TRUNCATED MOLECULES
#231Biochemical markers for CVD risk assessment
#232NOVEL PROTEINS WITH TARGETED BINDING
#233Protein scaffolds and uses thereof
#234Assay method for peptide specific T-cells
#235Determination of a specific immunoglobulin using multiple antigens
#236Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#237Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens
#238METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#239Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#240Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
#241Diagnostic And Therapeutic Epitope, And Transgenic Plant
#242Cytokines and Cytokine Receptors With Reduced Immunocencity
#243Methods For Immuno-Detection Of Epitopes On Molecules And For Detection Of Interactions Of Molecules Via Fluorescent Dyes
#244Aptameric IgE peptides in a protein scaffold as an allergy vaccine
#245Real time binding analysis of antigens on a biosensor surface
#246Identification of Immunologically Effective Epitopes on the Surface of Red Blood Cells and Their Use in a Method of Inducing Tolerance Thereto
#247Subtilism Carlsberg Proteins With Reduced Immunogencity
#248CYTOTOXIC T-CELL EPITOPE PEPTIDE AND USE THEREOF
#249Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
#250Methods of determining allergen response using microarray immunoassay techniques
#251AGENTS FOR AND METHOD OF QUANITIFYING MULTIPLE RELATED COMPONENTS IN A BIOLOGICAL SYSTEM
#252Allo and Auto-Reactive T-Cell Epitopes
#253Comparative ligand mapping from MHC class I positive cells
#254Sensors and methods for detecting diseases caused by a single point mutation
#255Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections
#256Binding reagents that contain small epitope binding molecules
#257METAL CHELATE-LABELLED PEPETIDES
#258Diagnostic and therapeutic epitope, and transgenic plant
#259Method to identify epitopes
#260Identification of self and non-self antigens implicated in autoimmune disease
#261Immunointeractive molecules and uses thereof
#262System and method for modulating a humoral immune response
#263System and method for modulating a humoral immune response
#264System and method for modulating a humoral immune
#265Method for identifying and quantifying of tumuor-associated
#266Reagents, kits and methods for immunodetection of epitopes on molecules
#267Compositions and methods for the therapy and diagnosis of breast cancer
#268Computational methods and systems to reinforce a humoral immune response
#269Conformational and topological protein regulation
#270Protein splice variant/isoform discrimination and quantitative measurements thereof
#271Protein isoform discrimination and quantitative measurements thereof
#272Diabetogenic epitopes
#273Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
#274Method for localizing and identifying isotopes
#275HPV CD8+ T-cell epitopes
#276Antigens
#277Comparative ligand mapping from MHC positive cells
#278Methods and Compositions for Inhibiting C-MET Dimerization and Activation
#279Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#280Methods of identifying optimal variants of peptide epitopes
#281Epitope testing using soluble HLA
#282De-immunized streptokinase
#283PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM
#284Peptide epitopes common to antigens of the same multigene family
#285Protein scaffolds and uses thereof
#286Mapping discontinuous antibody or aptamer epitopes for protein structure determination and other applications
#287Real time binding analysis of antigens on a biosensor surface
#288Method for identifying and designing immunogenic peptides
#289System and method for modulating a humoral immune response
#290Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof
#291Compositions and methods for epitope mapping
#292Immunoassay
#293Antigenic fragments of human factor VIII polypeptides
#294Immune response assessment method
#295Epitope testing using soluble HLA
#296Conformational and topological protein regulation
#297Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same
#298Assay for TSG101 as inhibitors of HIV production
#299Method for identification of proteins from intracellular bacteria
#300Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood